Piccart, M. J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

101

P118 ALTTO (adjuvant lapatinib and/or trastuzumab treatment optimisation) study [BIG 2-06/N063D/EGF106708]: a phase III study for HER2-overexpressing early breast cancer (BC)

M.J. Piccart-Gebhart, E.A. Perez, J. Baselga, R.D. Gelber, D. Rosa, E. Azambuja, C. Oliva, A. Goldhirsch

Journal:

Year:

2007

Language:

english

File:

PDF, 58 KB

english, 2007

102

P124 neo-ALTTO (neoadjuvant lapatinib and/or trastuzumab treatment optimisation) study [BIG 1-06/SOLTI/EGF106903]: a phase III translational study for Her2-overexpressing early breast cancer (BC)

J. Baselga, M.J. Piccart-Gebhart, R.D. Gelber, S. di Cosimo, G. Viale, M. Koehler, F. Rojo

Journal:

Year:

2007

Language:

english

File:

PDF, 45 KB

english, 2007

103

S5 Aiming at the target: In the crosshairs or the crossfire?

M. Piccart-Gebhart, P.L. Bedard, P. Dinh

Journal:

Year:

2009

Language:

english

File:

PDF, 59 KB

english, 2009

104

S25 Update of the HERA trial and the role of 1 year Trastuzumab as adjuvant therapy for breast cancer

L. Gianni, A. Goldhirsch, R.D. Gelber, E. Azambuja, M. Procter, M. Untch, I. Smith, C. Jackisch, D. Cameron, S. Muehlbauer, B. Leyland-Jones, M. Piccart-Gebhart, J. Baselga, R. Bell

Journal:

Year:

2009

Language:

english

File:

PDF, 51 KB

english, 2009

105

Aiming at the target: improved adjuvant medical therapy

Philippe L. Bedard, Phuong Dinh, Christos Sotiriou, Martine J. Piccart-Gebhart

Journal:

Year:

2009

Language:

english

File:

PDF, 220 KB

english, 2009

106

S02 Beyond trastuzumab: new anti-HER2 agents

M. Piccart, K. Saini, H. Azim, O. Metzger, E. de Azambuja

Journal:

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

107

Beyond trastuzumab: New treatment options for HER2-positive breast cancer

Kamal S. Saini, Hatem A. Azim Jr, Otto Metzger-Filho, Sherene Loi, Christos Sotiriou, Evandro de Azambuja, Martine Piccart

Journal:

Year:

2011

Language:

english

File:

PDF, 255 KB

english, 2011

108

Locally-advanced breast cancer: the EORTC-Breast cancer cooperative group experience

Journal:

Year:

1997

Language:

english

File:

PDF, 134 KB

english, 1997

109

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

Jérôme Toussaint, Anieta M Sieuwerts, Benjamin Haibe-Kains, Christine Desmedt, Ghizlane Rouas, Adrian L Harris, Denis Larsimont, Martine Piccart, John A Foekens, Virginie Durbecq, Christos Sotiriou

Journal:

Year:

2009

Language:

english

File:

PDF, 811 KB

english, 2009

110

Comparison of prognostic gene expression signatures for breast cancer

Benjamin Haibe-Kains, Christine Desmedt, Fanny Piette, Marc Buyse, Fatima Cardoso, Laura van't Veer, Martine Piccart, Gianluca Bontempi, Christos Sotiriou

Journal:

Year:

2008

Language:

english

File:

PDF, 297 KB

english, 2008

111

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

Hichame Id Boufker, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean-Jacques Body, Fabrice Journé

Journal:

Year:

2010

Language:

english

File:

PDF, 813 KB

english, 2010

112

Potential Predictive Value of Bcl-2 for Response to Tamoxifen in the Adjuvant Setting of Node-Positive Breast Cancer

Fatima Cardoso, Marianne Paesmans, Denis Larsimont, Virginie Durbecq, Chantal Bernard-Marty, Ghizlane Rouas, Stella Dolci, Christos Sotiriou, Martine J. Piccart, Angelo Di Leo

Journal:

Clinical Breast Cancer

Year:

2004

Language:

english

File:

PDF, 136 KB

english, 2004

113

Bringing Molecular Prognosis and Prediction to the Clinic

Mariantonietta Colozza, Fatima Cardoso, Christos Sotiriou, Denis Larsimont, Martine J. Piccart

Journal:

Clinical Breast Cancer

Year:

2005

Language:

english

File:

PDF, 761 KB

english, 2005

114

HER2-Positive Breast Cancer: From Trastuzumab to Innovatory Anti-HER2 Strategies

Nicolas Whenham, Véronique D'Hondt, Martine J. Piccart

Journal:

Clinical Breast Cancer

Year:

2008

Language:

english

File:

PDF, 352 KB

english, 2008

115

Current Paradigms for the Use of HER2-Targeted Therapy in Early-Stage Breast Cancer

Philippe L. Bedard, Martine J. Piccart-Gebhart

Journal:

Clinical Breast Cancer

Year:

2008

Language:

english

File:

PDF, 141 KB

english, 2008

116

Expert Roundtable: Emerging Questions in ErbB2-Positive Breast Cancer; February 22, 2007

Mark Pegram, Edith A. Perez, Martine Piccart, Neil Spector

Journal:

Clinical Breast Cancer

Year:

2008

Language:

english

File:

PDF, 101 KB

english, 2008

117

Kinetics of Adenosine 3′:5′-monophosphate Accumulation in Dog Thyroid Slices

Stéphane SWILLENS, Jacqueline VAN SANDE, Roland POCHET, Dominique DELBEKE, Martine PICCART, Manuel PAIVA, Jacques E. DUMONT

Journal:

Year:

1976

Language:

english

File:

PDF, 634 KB

english, 1976

118

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

Metzger-Filho, O., Tutt, A., de Azambuja, E., Saini, K. S., Viale, G., Loi, S., Bradbury, I., Bliss, J. M., Azim, H. A., Ellis, P., Di Leo, A., Baselga, J., Sotiriou, C., Piccart-Gebhart, M.

Journal:

Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 138 KB

english, 2012

119

Cytotoxic agents with activity in breast cancer patients previously exposed to anthracyclines: Current status and future prospects

M.J. Piccart, E. Raymond, M. Aapro, E.A. Eisenhauer, E. Cvitkovic

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 975 KB

english, 1995

120

Docetaxel in advanced ovarian cancer: Preliminary results from three phase II trials

S.B. Kaye, M. Piccart, M. Aapro, J. Kavanagh

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 329 KB

english, 1995

121

348 A phase II trial of docetaxel in patients (PTS) with anthracycline resistant (AR) metastatic breast cancer (MBC)

J.P. Guastalla, J. Bonneterre, P. Fumoleau, M. Piccart, M. Tubiana, B. Chevallier, C. Nieamann, M. Alakl, A. Nichol, A. Riva, M. Marty

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 269 KB

english, 1995

122

372 Neo-adjuvant chemotherapy in locally advanced beast cancer (LABC): FEC (5FU, epirubicin, cyclophosphamide) vs high dose intensity EC + G-CSF (Filgrastim). An EORTC—NCIC—SAKK study. Preliminary results of dose intensity (DI)

P. Therasse, C. Tsitsa, T. Sahmoud, E. Tomiak, A. Goldhirsch, M. Piccart

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 154 KB

english, 1995

123

347 Steroids do reduce the severity and delay the onset of docetaxel (DXT) induced fluid retention: Final results of a randomized trial of the EORTC investigational drug branch for breast cancer (IDBBC)

M.J. Piccart, J. Klijn, R. Paridaens, M. Nooij, L. Mauriac, R. Coleman, A. Awada, J. Selleslags, A. Van Vreckem, M. Van Glabbeke

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 126 KB

english, 1995

124

346 Taxol or doxorubicin as first line chemotherapy in advanced breast cancer (ABC). A prospective randomized phase II study with crossover

R. Paridaens, P. Bruning, F. Calabresi, A. Awada, J.A. Roy, Z. Kusenda, M. Piccart

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 126 KB

english, 1995

125

Characterisation of complete responders to combination chemotherapy for advanced breast cancer: A retrospective EORTC breast group study

E. Tomiak, M. Piccart, F. Mignolet, T. Sahmoud, R. Paridaens, M. Nooy, L. Beex, I.S. Fentiman, A. Muller, E. van der Schueren

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 1.05 MB

english, 1996

126

PP-6-24 A Retrospective Analysis of 124 Cases on the Different Clinical Outcome for Patients with ER−/PR+ Breast Tumors as Compared with ER−/PR−

J.A. Roy, F. Jacob, G. Leclerc, M.J. Piccart

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 155 KB

english, 1996

127

PP-8-1 Combined estroyen suppression and receptor (ER) blockade by buserelin (LHRH-A) and tamoxifen (TAM) in premenopausal metastatic breast cancer: Preliminary results of a 3-arm randomized study (EORTC 10881)

J.G.M. Klijn, C. Seynaeve, L. Beex, L. Mauriac, J. van Zijl, C. Veyret, J. Wildiers, J. Jassem, J. Burghouts, M. Becquart, M. Namer, M. Piccart, J. Garcia-Conde, F. Mignolet, G. Hoctin-Boes

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 182 KB

english, 1996

128

PP-8-6 Paclitaxel (P) versus doxorublcin (D) as first line chemotherapy (CT) in advanced breast cancer (ABC): A randomized trial with crossover of the EORTC-IDBBC in collaboration with EORTC-ECSG

P. Bruning, M.J. Piccart, J. Klijn, T. Gamucci, Z. Kusenda, J.A. Roy, A. Van Vreckem, R. Paridaens, IDBBC

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 179 KB

english, 1996

129

PP-8-15 Phase II studies with Rlvfzor® (Vorozole) in Advanced Breast Cancer

M. Piccart, J.A. Roy

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 176 KB

english, 1996

130

SY-8-3 New drugs other than chemotherapeutic or hormonal agents: The hope for innovative treatment strategies against breast cancer

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 151 KB

english, 1996

131

PP-7-12 Dose-finding study of weekly oral vinorelbine (VRL) in patients (PTS) with advanced breast cancer (ABC): preliminary results

B. Chevallier, J. Bonneterre, P. Hurteloup, C. Focan, L Mauriac, M. Piccart, E. Favreau, I. Sénac

Journal:

European Journal of Cancer

Year:

1996

Language:

english

File:

PDF, 181 KB

english, 1996

132

Molecular targeted therapies in breast cancer: Where are we now?

Christian Widakowich, Evandro de Azambuja, Thierry Gil, Fatima Cardoso, Phuong Dinh, Ahmad Awada, Martine Piccart-Gebhart

Journal:

The International Journal of Biochemistry & Cell Biology

Year:

2007

Language:

english

File:

PDF, 225 KB

english, 2007

133

The Src inhibitor dasatinib inhibits breast cancer cell growth in vitro and exerts synergistic effects with bisphosphonates

Fabrice Journe, Naima Kheddoumi, Carole Chaboteaux, Christos Sotiriou, Martine Piccart, Jean-Jacques Body

Journal:

Year:

2008

Language:

english

File:

PDF, 67 KB

english, 2008

134

Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer

F Efficace, L Biganzoli, M Piccart, C Coens, K Van Steen, T Cufer, R.E Coleman, H.A Calvert, T Gamucci, C Twelves, P Fargeot, A Bottomley

Journal:

European Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 244 KB

english, 2004

135

The Hamburg statement: the partnership driving the European agenda on breast cancer

J Jassem, M Buchanan, F Jänicke, M Baum, L Cataliotti, S Kyriakides, M Piccart, E.J.T Rutgers, A Costa

Journal:

European Journal of Cancer

Year:

2004

Language:

english

File:

PDF, 128 KB

english, 2004

136

Will the dark sky over advanced renal cell carcinoma soon become brighter?

V. D’Hondt, T. Gil, Y. Lalami, M. Piccart, Ahmad Awada

Journal:

European Journal of Cancer

Year:

2005

Language:

english

File:

PDF, 125 KB

english, 2005

137

Fulvestrant – ready to start its journey in the breast cancer adjuvant endocrine world?

M.J. Piccart-Gebhart, S.M. Loi

Journal:

European Journal of Cancer

Year:

2005

Language:

english

File:

PDF, 224 KB

english, 2005

138

Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?

D. Strumberg, A. Awada, H. Hirte, J.W. Clark, S. Seeber, P. Piccart, E. Hofstra, D. Voliotis, O. Christensen, A. Brueckner, B. Schwartz

Journal:

European Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 163 KB

english, 2006

139

What clinicians need to know about antioestrogen resistance in breast cancer therapy

Amalia Milano, Lissandra Dal Lago, Christos Sotiriou, Martine Piccart, Fatima Cardoso

Journal:

European Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 385 KB

english, 2006

140

Adjuvant trastuzumab therapy for HER2-overexpressing breast cancer: What we know and what we still need to learn

Martine J. Piccart-Gebhart

Journal:

European Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 119 KB

english, 2006

141

Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)

L. Beex, C. Rose, H. Mouridsen, J. Jassem, M. Nooij, J. Estape, R. Paridaens, M. Piccart, T. Gorlia, S. Lardenoije, L. Baila

Journal:

European Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 230 KB

english, 2006

142

The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase I study with pharmacokinetics

Ahmad Awada, Fatima Cardoso, Christel Fontaine, Luc Dirix, Jacques De Grève, Christos Sotiriou, Jutta Steinseifer, Carine Wouters, Chiaki Tanaka, Ulrike Zoellner, Pui Tang, Martine Piccart

Journal:

European Journal of Cancer

Year:

2008

Language:

english

File:

PDF, 175 KB

english, 2008

143

The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase

Emiel Rutgers, Martine J. Piccart-Gebhart, Jan Bogaerts, Suzette Delaloge, Laura Van ‘t Veer, Isabel Teresa Rubio, Giuseppe Viale, Alastair M. Thompson, Rodolfo Passalacqua, Ulrike Nitz, Anita Vindevo

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 280 KB

english, 2011

144

Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours

Ahmad Awada, Alain Hendlisz, Olaf Christensen, Chetan D. Lathia, Sylvie Bartholomeus, Fabienne Lebrun, Dominique de Valeriola, Erich Brendel, Martin Radtke, Thierry Delaunoit, Martine Piccart-Gebhart,

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 225 KB

english, 2012

145

Impaired appetitively as well as aversively motivated behaviors and learning in PDE10A-deficient mice suggest a role for striatal signaling in evaluative salience attribution

Elisabeth Piccart, Ilse Gantois, Annelies Laeremans, Ronald de Hoogt, Theo Meert, Greet Vanhoof, Lutgarde Arckens, Rudi D’Hooge

Journal:

Neurobiology of Learning and Memory

Year:

2011

Language:

english

File:

PDF, 833 KB

english, 2011

146

Chromogenic in Situ Hybridization: A Practical Alternative for Fluorescence in Situ Hybridization to Detect HER-2/neu Oncogene Amplification in Archival Breast Cancer Samples

Minna Tanner, David Gancberg, Angelo Di Leo, Denis Larsimont, Ghizlane Rouas, Martine J. Piccart, Jorma Isola

Journal:

The American Journal of Pathology

Year:

2000

Language:

english

File:

PDF, 451 KB

english, 2000

147

Trastuzumab after adjuvant chemotherapy in older patients – Authors' reply

Ian E Smith, Marion Procter, Richard Gelber, Martine Piccart-Gebhart

Journal:

Year:

2007

Language:

english

File:

PDF, 47 KB

english, 2007

148

ICON2 trial

Journal:

Year:

1999

Language:

english

File:

PDF, 60 KB

english, 1999

149

Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer

Fatima Cardoso, Angelo Di Leo, Martine J. Piccart

Journal:

Cancer Treatment Reviews

Year:

2002

Language:

english

File:

PDF, 620 KB

english, 2002

150

New cytotoxic agents

Martine Piccart

Journal:

Cancer Treatment Reviews

Year:

1997

Language:

english

File:

PDF, 559 KB

english, 1997